This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.

Accept

Staff at the Cancer Research Institute's headquarters in New York City hold special expertise in nonprofit management and development, scientific and medical communications, event planning, and grants administration. Our team is passionate about saving more lives with cancer immunotherapy.

CEO
Jill O'Donnell-Tormey, Ph.D.
Chief Executive Officer and Director of Scientific Affairs
Senior Staff
Brian M. Brewer
Director of Marketing and Communications
Jay Campbell
Managing Director of CRI Clinical Accelerator and Venture Fund
Lynne A. Harmer
Director of Grants Administration and Special Events
Rupinder Kaur
Director of Data Systems and Operations
Deanne Marbach
Director of Major Gifts
Alfred R. Massidas
Chief Financial Officer and Director of Human Resources
Sharon Slade
Director of Strategic Initiatives
People
Arthur N. Brodsky, Ph.D.
Senior Science Writer
Janet Fernandez
Assistant to the CEO
Kelly Flynn
Front End Administrative Assistant
Ryan Godfrey
Grants Administrator
Cierra Howard
Community Fundraising Coordinator
Rachel Jones
Assistant to the Director of Strategic Initiatives
Marla S. Lawson
Associate Director of Corporate and Foundation Relations
Robert Levine, MBA
Project Manager
Jasmine Lingard
Senior Manager of Special Events
Shasell Negron
Community Fundraising Manager
Alice Northover
Senior Marketing Manager
Caroline Offit
Associate Director of Patient Engagement
Lillian Ramos
Administrative Assistant
Kajol Sankar
Donation Processing Assistant
Chary Sathea
Social Media Manager
Alexa Schles
Graphic Designer
Devi Sharma
Donations Processing Manager
Samik Upadhaya, Ph.D.
Research Analyst
Jia Xin "Annie" Yu, Ph.D.
Data Scientist
Qing Hua Zhang
Controller
Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.

CRI.ContactUs

Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111

800-992-2623212-832-9376Staff Directory

Stay Connected with CRI

Follow us

Recent Blog Posts

In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy for non-small cell lung cancer.

Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.
Top